Evidence map›Paper›PMID 30589913›Full record

ArticlePloS one2018

Surviving Ebola: A historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015.

Kevin Wing, Shefali Oza, Catherine Houlihan, Judith R Glynn, Sharon Irvine, Clare E Warrell, Andrew J H Simpson, Sabah Boufkhed, Alieu Sesay, Lahai Vandi and 5 more

Open access · goldAbstract readHistorical Article
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A Review of Hearing Loss Associated with Zika, Ebola, and Lassa Fever.The American journal of tropical medicine and hygiene · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Kevin WingSave the Children International, Kerry Town, Sierra Leone.ORCID 0000-0003-2335-9641
Shefali OzaSave the Children International, Kerry Town, Sierra Leone.
Catherine HoulihanDivision of Infection and Immunity, University College London, London, United Kingdom.
Judith R GlynnLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Sharon IrvineSave the Children International, Kerry Town, Sierra Leone.
Clare E WarrellSave the Children International, Kerry Town, Sierra Leone.
Andrew J H SimpsonRare and Imported Pathogens Laboratory, Public Health England, Porton, Wilts, United Kingdom.
Sabah BoufkhedSave the Children International, Kerry Town, Sierra Leone.
Alieu SesaySave the Children International, Kerry Town, Sierra Leone.
Lahai VandiSave the Children International, Kerry Town, Sierra Leone.
Sahr Charles SebbaSave the Children International, Kerry Town, Sierra Leone.
Pranav ShettyHumanitarian Public Health Technical Unit, Save the Children, London, United Kingdom.
Rachael CummingsHumanitarian Public Health Technical Unit, Save the Children, London, United Kingdom.
Francesco ChecchiSave the Children International, Kerry Town, Sierra Leone.
Catherine R McGowanSave the Children International, Kerry Town, Sierra Leone.
London School of Hygiene & Tropical Medicine · GBSave the Children · GBPublic Health England · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile a number of predictors for Ebola mortality have been identified, less is known about post-viral symptoms. The identification of acute-illness predictors for post-viral symptoms could allow the selection of patients for more active follow up in the future, and those in whom early interventions may be beneficial in the long term. Studying predictors of both mortality and post-viral symptoms within a single cohort of patients could also further our understanding of the pathophysiology of survivor sequelae. METHODS/PRINCIPAL

findingsWe performed a historical cohort study using data collected as part of routine clinical care from an Ebola Treatment Centre (ETC) in Kerry Town, Sierra Leone, in order to identify predictors of mortality and of post-viral symptoms. Variables included as potential predictors were sex, age, date of admission, first recorded viral load at the ETC and symptoms (recorded upon presentation at the ETC). Multivariable logistic regression was used to identify predictors. Of 263 Ebola-confirmed patients admitted between November 2014 and March 2015, 151 (57%) survived to ETC discharge. Viral load was the strongest predictor of mortality (adjusted OR comparing high with low viral load: 84.97, 95% CI 30.87-345.94). We did not find evidence that a high viral load predicted post-viral symptoms (ocular: 1.17, 95% CI 0.35-3.97; musculoskeletal: 1.07, 95% CI 0.28-4.08). Ocular post-viral symptoms were more common in females (2.31, 95% CI 0.98-5.43) and in those who had experienced hiccups during the acute phase (4.73, 95% CI 0.90-24.73). CONCLUSIONS/SIGNIFICANCE: These findings may add epidemiological support to the hypothesis that post-viral symptoms have an immune-mediated aspect and may not only be a consequence of high viral load and disease severity.

Indexed as

EbolavirusAdolescentAdultCohort StudiesDisease OutbreaksFemaleHemorrhagic Fever, EbolaHistory, 21st CenturyHumansMaleMortalityPopulation SurveillanceRisk FactorsSierra LeoneSurvivorsViral Load

Identifiers

PMID30589913
PMCPMC6307710
OpenAlexW2907113562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.